Bremelanotide PT-141

Bremelanotide PT-141 is a new and innovative treatment for erectile dysfunction and other sexual dysfunctions in men. This new and improved treatment option has shown to be highly effective in clinical trials, with a success rate of over 80%.

Bremelanotide PT-141 is a peptide that is being studied for its potential use in treating sexual dysfunction in men. It is a melanocortin receptor agonist, which means it works by stimulating the release of the hormone melanocortin. Melanocortin is involved in a number of different physiological processes, including sexual arousal and erections. PT-141 had shown promise in animal studies, causing increased sexual activity in both male and female rats. Now, this is being translated to human use.

Type: Injectable

Location: subcutaneous (fat)

Dose: 10 units (1mg) twice per week

Storage: Refrigerator

Prescription: Yes

Disclaimer: Will darken skin over time

Purchase Now

Benefits of Bremelanotide PT-141

Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Women:Bremelanotide has been approved for treating generalized HSDD in premenopausal women. It enhances sexual desire and reduces associated distress without underlying medical, psychiatric, or relationship issues.
Alternative for Erectile Dysfunction (ED) in Men:For men who do not respond to phosphodiesterase type 5 inhibitors (e.g., sildenafil), PT-141 offers an alternative by directly stimulating central mechanisms involved in sexual arousal.
Central Mechanism of Action:By targeting melanocortin receptors in the brain, PT-141 may address sexual dysfunctions linked to central nervous system factors, offering a different approach from peripheral vascular treatments.
Potential for Broader Sexual Enhancement:Beyond treating specific disorders, PT-141 may enhance overall sexual experiences by increasing libido and arousal in both men and women.

Medication Information

Who can use PT-141?

PT-141 is primarily used for:

Women with hypoactive sexual desire disorder (HSDD)
Men with erectile dysfunction (ED), especially those unresponsive to PDE5 inhibitors (like Viagra)
Individuals looking to enhance libido and sexual experiences

Proper Use

PT-141 is usually given as a subcutaneous injection, typically in the abdomen or thigh. It is taken as needed, about 30-60 minutes before sexual activity.

How to prepare the injection.

Proper use of disposable syringes and needles, including safe handling and disposal.
How to give the injection.
How long the injection is safe to use.

How long do the effects last?

PT-141’s effects can last anywhere from 6 to 12 hours, with some users reporting residual benefits for up to 24 hours.

Storage

Use within 30 to 60 days, depending on manufacturer guidelines.

Avoid freezing the solution, as it can degrade the peptide.

Available in select U.S. states. Eligibility is determined by the provider. Compounded semaglutide and tirzepatide are not FDA-approved for weight loss. It is prescribed only when deemed medically appropriate by a licensed provider after review. Individual results vary significantly based on factors like adherence, diet, exercise, and health status. No guarantees of weight loss. GLP-1 medications like semaglutide may increase the risk of thyroid C-cell tumors based on animal studies; human risk is not confirmed. Services provided by licensed physicians/nurse practitioners in states served, e.g., CA, FL, and others, via telemedicine. Check your state's telemedicine laws. We prioritize your privacy and comply with HIPAA regulations for protected health information. Must be 18 or older.

Bremelanotide PT-141

Bremelanotide PT-141

Benefits of Bremelanotide PT-141

Medication Information

Featured Products

This website uses cookies.